Literature DB >> 6387891

Secretory otitis media: microbiology of the middle ear and the nasopharynx.

C Kamme, N I Nilsson.   

Abstract

Specimens for bacterial culture were obtained from 117 children with secretory otitis media (SOM). From the nasopharynx Streptococcus pneumoniae, Haemophilus influenzae, Branhamella catarrhalis and group A streptococci were isolated in 79% of the patients. Of 168 ear exudates, 30 yielded growth (18%) from 26 of the patients (22%). Pneumococcal capsular polysaccharides could not be detected in exudates assayed by counterimmunoelectrophoresis. The recovery rate of bacteria from the ear exudates was significantly higher in patients with positive than with negative nasopharyngeal culture (p less than 0.05). The nasopharyngeal pathogens invading the middle ear in SOM seem to survive there for a period of time and are then replaced by other strains according to the fluctuation of the nasopharyngeal flora where approximately 40% of the strains were eliminated and replaced by other strains over a period of 12 to 13 days.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387891     DOI: 10.3109/00365548409070403

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  Determination of the epidemiology and transmission of nontypable Haemophilus influenzae in children with otitis media by comparison of total genomic DNA restriction fingerprints.

Authors:  B G Loos; J M Bernstein; D M Dryja; T F Murphy; D P Dickinson
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Microbiological perspectives of co-trimoxazole.

Authors:  A Bauernfeind; G Hörl; B Przyklenk
Journal:  Infection       Date:  1987       Impact factor: 3.553

3.  Beta-lactamase production in the upper respiratory tract flora.

Authors:  I Eliasson; C Kamme; K Prellner
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

4.  Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.

Authors:  I Eliasson; C Kamme
Journal:  Drugs       Date:  1986       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.